AVB-101 / AviadoBio 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AVB-101 / AviadoBio
2022-002568-62: A study to test whether AVB-101 is both safe and efficacious in a sub-population of genetically defined FTD patients that currently have no other treatment options Un estudio para probar si AVB-101 es seguro y eficaz en una subpoblación de pacientes con DFT genéticamente definidos que actualmente no tienen otras opciones de tratamiento.

Not yet recruiting
1/2
15
Europe
Recombinant AAV-9 vector expressing the human progranulin protein, AVB-101, Solution for injection
AviadoBio Ltd, AviadoBio Limited
Frontotemporal Dementia With Progranulin Mutations (FTD-GRN) Demencia Frontotemporal con mutaciones en el gen de la progranulina (DFT-GRN), Dementia Demencia, Diseases [C] - Nervous System Diseases [C10]
 
 
ASPIRE-FTD, NCT06064890 / 2022-002568-62: A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

Recruiting
1/2
9
Europe, US
Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101
AviadoBio Ltd, AviadoBio Limited
Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal
04/26
10/30
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AVB-101 / AviadoBio
2022-002568-62: A study to test whether AVB-101 is both safe and efficacious in a sub-population of genetically defined FTD patients that currently have no other treatment options Un estudio para probar si AVB-101 es seguro y eficaz en una subpoblación de pacientes con DFT genéticamente definidos que actualmente no tienen otras opciones de tratamiento.

Not yet recruiting
1/2
15
Europe
Recombinant AAV-9 vector expressing the human progranulin protein, AVB-101, Solution for injection
AviadoBio Ltd, AviadoBio Limited
Frontotemporal Dementia With Progranulin Mutations (FTD-GRN) Demencia Frontotemporal con mutaciones en el gen de la progranulina (DFT-GRN), Dementia Demencia, Diseases [C] - Nervous System Diseases [C10]
 
 
ASPIRE-FTD, NCT06064890 / 2022-002568-62: A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

Recruiting
1/2
9
Europe, US
Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101
AviadoBio Ltd, AviadoBio Limited
Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal
04/26
10/30

Download Options